Efficacy and Safety of Tamsulosin for Treating Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia: A Multicenter, Randomized, Controlled, Open-Label Non-Inferiority Study

PURPOSE: To compare the efficacy and safety of Sulosin D (PACIFICPHARMA, Korea) and Harnal D (ASTELLAS PHARMA KOREA, Korea) in treating patients with lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH). MATERIALS AND METHODS: This randomized, controlled, open-label, multi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Hyo Serk, Kim, Sae Woong, Oh, Seung-June, Choo, Myung-Soo, Lee, Kyu-Sung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Urological Association 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3312066/
https://www.ncbi.nlm.nih.gov/pubmed/22468213
http://dx.doi.org/10.4111/kju.2012.53.3.178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3312066/
https://www.ncbi.nlm.nih.gov/pubmed/22468213
http://dx.doi.org/10.4111/kju.2012.53.3.178

Ejemplares similares